97 related articles for article (PubMed ID: 35960)
1. Live tissue culture influenza vaccine for oral administration. I. Specific immune response to monovaccine A (H3N2) in volunteers.
Alekseeva AK; Andzhaparidze OG; Gracheva EN; Sidorova LA; Melnikova SK
Acta Virol; 1979 Jan; 23(1):59-66. PubMed ID: 35960
[TBL] [Abstract][Full Text] [Related]
2. Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination.
de Bruijn IA; Remarque EJ; Jol-van der Zijde CM; van Tol MJ; Westendorp RG; Knook DL
J Infect Dis; 1999 Jan; 179(1):31-6. PubMed ID: 9841819
[TBL] [Abstract][Full Text] [Related]
3. E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1).
Schmidt S; Süss J; Oehring H; Schmidt J
Acta Virol; 1982 Dec; 26(6):466-73. PubMed ID: 6132540
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.
Hehme N; Engelmann H; Kuenzel W; Neumeier E; Saenger R
Virus Res; 2004 Jul; 103(1-2):163-71. PubMed ID: 15163505
[TBL] [Abstract][Full Text] [Related]
5. Vaccination of an adolescent group with A (H3N2) + A(HSW1N1) bivaccine before an A (H1N1) influenza epidemic.
Stumpa A; Cihla F; Tůmová B; Husek V; Slezácek J
Acta Virol; 1979 Sep; 23(5):443-5. PubMed ID: 42307
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children.
Beutner KR; Rizzone C; DeMello S; Ogra PL
Dev Biol Stand; 1976; 33():162-70. PubMed ID: 782964
[TBL] [Abstract][Full Text] [Related]
7. Antibody responses to inactivated influenza vaccines and partial protective effect of anti-neuraminidase antibody against epidemics of A(H3N2) and A(H1N1) influenza.
Maeda A; Oishi I; Minekawa Y; Kunita N; Funahashi S; Yagura H
Biken J; 1979 Sep; 22(3):91-8. PubMed ID: 533537
[No Abstract] [Full Text] [Related]
8. Differences in antibody responses of mice to intranasal or intraperitoneal immunization with influenza A virus and vaccination with subunit influenza vaccine.
Fislová T; Sládková T; Gocník M; Mucha V; Varecková E; Kostolanský F
Acta Virol; 2005; 49(4):243-50. PubMed ID: 16402681
[TBL] [Abstract][Full Text] [Related]
9. Immune response to influenza vaccination in community-dwelling Chinese elderly persons.
Hui SL; Chu LW; Peiris JS; Chan KH; Chu D; Tsui W
Vaccine; 2006 Jun; 24(25):5371-80. PubMed ID: 16713661
[TBL] [Abstract][Full Text] [Related]
10. Persistence of influenza A/New Jersey/76 (Hsw1N1) antibody one year after vaccination.
Noble GR; Kaye HS; O'Brien RJ; Kendal AP; Bregman DJ; Wright PF; Amler RW; Dowdle WR
Dev Biol Stand; 1977 Jun 1-3; 39():253-60. PubMed ID: 604107
[TBL] [Abstract][Full Text] [Related]
11. Vaccination-induced HI antibody response to intraepidemic influenza A(H3N2) virus variants of the 1996-1997 epidemic season.
Pyhälä R; Ikonen N; Santanen R; Haanpää M; Visakorpi R; Jäppinen P; Valle M
J Med Virol; 2001 Nov; 65(3):584-9. PubMed ID: 11596097
[TBL] [Abstract][Full Text] [Related]
12. Assessment of resistance to influenza virus infection in animal models.
Potter CW; McLaren C; Jennings R
Dev Biol Stand; 1975; 28():307-18. PubMed ID: 1126574
[TBL] [Abstract][Full Text] [Related]
13. Cross-protection by MF59-adjuvanted influenza vaccine: neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses.
Ansaldi F; Bacilieri S; Durando P; Sticchi L; Valle L; Montomoli E; Icardi G; Gasparini R; Crovari P
Vaccine; 2008 Mar; 26(12):1525-9. PubMed ID: 18294741
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of cell-mediated immunity after oral administration of a live influenza vaccine.
Unanov SS; Yuminova NV; Akopova II
Acta Virol; 1982 Dec; 26(6):474-80. PubMed ID: 6132541
[TBL] [Abstract][Full Text] [Related]
15. Bile immunoglobulin of the duck (Anas platyrhynchos). II. Antibody response in influenza A virus infections.
Higgins DA; Shortridge KF; Ng PL
Immunology; 1987 Nov; 62(3):499-504. PubMed ID: 3451744
[TBL] [Abstract][Full Text] [Related]
16. Immune response after influenza vaccination in children with cancer.
Matsuzaki A; Suminoe A; Koga Y; Kinukawa N; Kusuhara K; Hara T
Pediatr Blood Cancer; 2005 Nov; 45(6):831-7. PubMed ID: 16007602
[TBL] [Abstract][Full Text] [Related]
17. In vitro production of anti-influenza virus antibody after intranasal inoculation with cold-adapted influenza virus.
Yarchoan R; Murphy BR; Strober W; Clements ML; Nelson DL
J Immunol; 1981 Nov; 127(5):1958-63. PubMed ID: 7299119
[TBL] [Abstract][Full Text] [Related]
18. [Antibody response to hemagglutinin and neuraminidase induced by an influenza subunit vaccine (author's transl)].
Kuwert E; Werner J; Franke G; Paulus W
Zentralbl Bakteriol Orig A; 1979 Jun; 244(1):1-16. PubMed ID: 92113
[TBL] [Abstract][Full Text] [Related]
19. [Antibody formation and preservation against the envelope antigens of influenza virus subtype A(H3N2) after infection and vaccination].
Stumpa A; Tůmová B
Tr Inst Im Pastera; 1982; 59():23-8. PubMed ID: 6764986
[No Abstract] [Full Text] [Related]
20. Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years.
Nabeshima S; Kashiwagi K; Murata M; Kanamoto Y; Furusyo N; Hayashi J
J Med Virol; 2007 Mar; 79(3):320-5. PubMed ID: 17245715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
